Welcome to Cleveland Clinic Online Health Chats

Get answers to your health questions and concerns. It's easy to be part of our live chat events, led by Cleveland Clinic physicians and health professionals.

Lung Cancer
Thursday, November 9, 2017 - 12 Noon (Eastern Time)

Sign up for this chat today.Register Now

Click Join Chat to join the chat in progress.You will be asked to login if you aren't already logged in.Join Chat

Usman Ahmad, MD

  • Thoracic Surgeon
  • Sydell and Arnold Miller Family Heart & Vascular Institute

Peter Mazzone, MD, MPH

  • Pulmonologist
  • Respiratory Institute

Gregory Videtic, MD, CM, FRCPC

  • Radiation Ocologist
  • Taussig Cancer Institute

Lung cancer is a very challenging cancer to treat. The most critical factor in determining the survival rate is the stage at the time of diagnosis. Using a multidisciplinary approach to lung cancer care is vital to managing the disease. Take this opportunity to have your questions answered by thoracic surgeon, Usman Ahmad, MD, pulmonologist, Peter Mazzone, MD, MPH, and radiation oncologist, Gregory Videtic, MD.

The Lung Cancer Program at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute, Imaging Pathology and Miller Family Heart & Vascular Institute, uses a multidisciplinary approach to cancer care. This allows us to focus our entire team’s expertise and energy on providing the best outcomes for our patients. Patients with lung cancer, mesothelioma and rare tumors of the chest wall and mediastinum (mid-chest cavity), can benefit from this comprehensive, coordinated care. While there is no one solution for treating lung cancer, there are many options.

Like other cancers, lung cancer develops when normal processes of cell division and growth are disrupted, giving way to abnormal, uncontrollable growth. The cells grow into a mass, or tumor. Any abnormal growth in the body that directly invades surrounding tissues and organs, spreads to other parts of the body, or has the potential to grow back after being removed is called “malignant,” or cancerous.

Lung cancer is the most common malignancy worldwide, with more than 1 million cases diagnosed yearly. In the United States, an estimated 224,000 new cases were diagnosed in 2014. More than 150,000 deaths in 2014 were due to lung cancer – making it the leading cause of cancer death in both men and women. Of those people born today, one in 14 men and women will be diagnosed with cancer of the lungs and bronchus (large air tubes leading from the windpipe to the lungs) during their lifetime.

Usman Ahmad, MD, is a thoracic surgeon in the Department of Thoracic and Cardiovascular Surgery at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He holds a joint appointment with the Taussig Cancer Institute. Dr. Ahmad is board-certified in surgery. He joined Cleveland Clinic in 2015.

Specialty interests include thoracic oncology; lung cancer; esophageal cancer; tracheal tumors; thymic tumors; chest wall tumors; minimally invasive thoracic surgery, including robotic, thorascopic, laparoscopic and bronchoscopic procedures; cancer outcomes; and general thoracic surgery.

Peter Mazzone, MD, MPH, is Staff and Director of Education at Cleveland Clinic's Respiratory Institute. Dr. Mazzone is board-certified in internal medicine, pulmonary medicine and critical care medicine.

His specialty interests include lung nodules, lung cancer and intensive care unit medicine. His research interests focus on breath analysis, lung cancer diagnostics, lung nodule evaluation, lung physiology assessment and lung cancer screening.

Gregory M.M. Videtic, MD, CM, FRCPC, received his medical degree from McGill University Faculty of Medicine in Montreal, Quebec, Canada. He completed a first residency in family medicine at Dalhousie University in Halifax, Nova Scotia. He is board-certified in Radiation Oncology.

His specialty interests include lung cancer, thoracic tumors, stereotactic body radiotherapy (SBRT) and image guided radiation therapy.

This Health Chat is currently open to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.